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Abstract
Background: Human immunodeficiency virus type one (HIV-1) is the major pathogen that causes the acquired
immune deficiency syndrome (AIDS). With the availability of large-scale protein-protein interaction (PPI)
measurements, comparative network analysis can provide a promising way to study the host-virus interactions and
their functional significance in the pathogenesis of AIDS. Until now, there have been a large number of HIV studies
based on various animal models. In this paper, we present a novel framework for studying the host-HIV
interactions through comparative network analysis across different species.
Results: Based on the proposed framework, we test our hypothesis that HIV-1 attacks essential biological pathways
that are conserved across species. We selected the Homo sapiens and Mus musculus PPI networks with the largest
coverage among the PPI networks that are available from public databases. By using a local network alignment
algorithm based on hidden Markov models (HMMs), we first identified the pathways that are conserved in both
networks. Next, we analyzed the HIV-1 susceptibility of these pathways, in comparison with random pathways in
the human PPI network. Our analysis shows that the conserved pathways have a significantly higher probability of
being intercepted by HIV-1. Furthermore, Gene Ontology (GO) enrichment analysis shows that most of the
enriched GO terms are related to signal transduction, which has been conjectured to be one of the major
mechanisms targeted by HIV-1 for the takeover of the host cell.
Conclusions: This proof-of-concept study clearly shows that the comparative analysis of PPI networks across
different species can provide important insights into the host-HIV interactions and the detailed mechanisms of HIV-1.
We expect that comparative multiple network analysis of various species that have different levels of susceptibility to
similar lentiviruses may provide a very effective framework for generating novel, and experimentally verifiable
hypotheses on the mechanisms of HIV-1. We believe that the proposed framework has the potential to expedite the
elucidation of the important mechanisms of HIV-1, and ultimately, the discovery of novel anti-HIV drugs.
Background
Acquired immune deficiency syndrome (AIDS), one of
the most destructive pandemics in recorded history
according to the statistics from the World Health Orga-
nization (WHO) [1], has killed more than 25 million
people since it was first recognized in 1981. Human
immunodeficiency virus type one (HIV-1) has been
found to be the causative pathogen of AIDS [2,3]. HIV-
1 is a lentivirus, a slow retrovirus that is responsible for
long-duration illness with a long incubation period.
HIV-1 has 9 genes which encode up to 19 proteins due
to post-translational cleavage [4]. By reverse transcrip-
tion from viral RNA to host-integrable DNA, the virus
can become active and replicate to cause rapid T cell
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infections that mark the advent of AIDS [5].
Although advances in antiviral therapy and manage-
ment of opportunistic infection for AIDS have remark-
ably improved the general health, the expensive cost and
adverse effects of the available drugs have motivated
many researchers to explore novel avenues to anti-HIV-1
drug discovery. With the increasing coverage of HIV-1
and human protein interactions in the literature [6-11], a
human/HIV-1 interactome has been created [12], which
can play a critical role in better understanding the virol-
ogy and pathology of this infectious disease and develop-
ing new therapeutics. In addition to this, the availability
of large-scale biological networks, including protein-pro-
tein interaction (PPI) networks, has led to the introduc-
tion of systems biology approaches for novel HIV-1 drug
discovery [13,14]. In [13], Balakrishnan et al. proposed to
find alternative pathways to circumvent the HIV-1 inter-
cepted pathways based on the efficiency and robustness
of biological processes. The main goal was to generate
new hypotheses regarding HIV-1 targeted pathways and
their effects on various molecular functions, which will
help us better understand the mechanisms of HIV-1
takeover of the host cell and find ways to circumvent it.
The study was based on curated signal transduction path-
w a y so b t a i n e df r o mm u l t i p l e pathway databases. One
practical problem of this pathway-based approach is that
the currently known pathways cover only a limited num-
ber of human proteins, hence it may exclude important
HIV-1 targets from the analysis. Moreover, many curated
pathways in public databases overlap with each other,
which may introduce bias in the analysis. On the other
hand, Lin et al. [14] proposed comparative studies of
host-virus protein interactions across human (Homo
sapiens) and other animal models that may be invaded by
similar lentiviruses that cause immunosuppression or
immunoproliferation, including three mammalian spe-
cies: chimpanzee (Pan troglodyte), rhesus macaque
(Macaca mulatta), and mouse (Mus musculus). All these
animal models have been extensively studied to under-
stand the HIV-1 host-virus interplay [15,16]. Compara-
tive studies of host-virus interactions may provide new
insights into why different species have different suscept-
ibility to HIV-1, which may lead to the development of
potential therapeutics in the long run.
Motivated by these works, we propose a novel frame-
work for studying human/HIV-1 interactions, based on
comparative analysis of the human PPI network and the
PPI network of other species that are susceptible to len-
tivirus invasion. It has been shown that the comparative
analysis of PPI networks of different species can identify
conserved pathways that carry essential cellular func-
tionalities [17-36]. Furthermore, HIV-1 has to be a
“minimalist” in order to survive, and for this reason, it
has been believed to target these essential pathways that
are conserved across species [13,37]. As a result, the
c o m p a r a t i v ea n a l y s i so fP P In e t w o r k sm a yb eu s e dt o
generate new hypotheses that will be useful in improv-
ing our understanding of the mechanisms of HIV-1
takeover of the host cell, and ultimately, for developing
effective therapeutics for AIDS.
Results and discussion
Conserved pathways are susceptible to HIV-1 attacks
Our main goal in this paper is to validate the following
hypothesis:
“Essential biological pathways that are conserved
across different species that are susceptible to lenti-
viruses, have a high probability of being intercepted by
HIV-1.”
To validate the above hypothesis, we first aligned the
Homo sapiens PPI network with the Mus musculus PPI
network to find conserved pathways (Figure 1). The
Mus musculus network was chosen as it is the largest
animal network under lentivirus study that is available
from public databases. This will allow us to reduce the
bias that may arise from using smaller networks. For
identifying conserved pathways, we used a local network
alignment method based on hidden Markov models
(HMMs), which we recently proposed in [36]. The
HMM framework can naturally integrate both the
“sequence similarity” of the proteins across different
species and the “interaction reliability” between the pro-
teins within the same PPI network into the scoring
scheme for finding conserved pathways. The HMM-
based local alignment method allows flexible number of
consecutive insertions and/or deletions, and it can deal
with a large class of path isomorphism. More impor-
tantly, the computational complexity for finding the best
matching pathways grows linearly with respect to the
size of each network, making it suitable for finding long
conserved pathways in large PPI networks. We ran the
HMM-based local alignment algorithm to find con-
served pathways both with and without gaps. Since the
Mus musculus network is still quite sparse (see Meth-
ods), the number of conserved pathways depends on
whether we allow gaps and how long the pathways can
be. Typically, we have fewer conserved pathways when
we search for long pathways with no gaps allowed.
Next, we extracted 3,000 random pathways of different
sizes (L = 16, 32, and 64) by performing a random walk
on the Homo sapiens network (see Methods). Then we
compared the HIV-1 susceptibility of the conserved
pathways with that of the random pathways in the
Homo sapiens P P In e t w o r k ,b yu s i n gt h ep r e d i c t e d
human/HIV-1 interactome map in [12].
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Page 2 of 10Number of proteins in the pathways that are intercepted
by HIV-1
Based on the identified conserved pathways and the ran-
domly extracted pathways, we first computed how many
proteins within each pathway can be intercepted by
HIV-1, by mapping the predicted human/HIV-1 interac-
tions in [12] onto these pathways. Figure 2 shows the
histogram of the number of HIV-1 interacting proteins
in conserved pathways as well as the histogram for ran-
dom pathways. From the figure, there is a clear distinc-
tion between the two types of histograms. Typically, the
separation between the two histograms increases with
the length of the pathways. We can clearly see that
highly conserved pathways are more susceptible to
HIV-1 interception, in general.
Next, we considered conserved pathways that have
been identified by the HMM-based local network align-
ment algorithm by allowing gaps. We compared the
histograms for these pathways to the histograms for
random pathways. These results are shown in Fig. 3. We
can see that the histograms show similar trends as in
Fig. 2, but the separation between the two types of his-
tograms is smaller in this case. This might be due to the
fact that the HMM-based algorithm may find less con-
served pathways when we allow gaps.
To evaluate the statistical significance of the difference
between conserved and random pathways, we estimated
the p-value of the number of HIV-1 interacting proteins
for every conserved pathway. The detailed process for
computing the p-values is described in Methods.B a s i -
cally, it computes the statistical significance of the num-
ber of HIV-1 interacting proteins in each conserved
pathway with respect to the baseline distribution, which
is estimated from the histogram of the number of
HIV-1 interacting proteins in randomly extracted path-
ways. Figure 4(A) shows the plot of p-values for con-
served pathways of various lengths and with no gaps
allowed. Conserved pathways with gaps show a similar
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Figure 2 The number of proteins that interact with HIV-1 proteins in conserved pathways (with no gaps) and randomly extracted pathways.
(A) The histograms for pathways of size L = 16. (B) The histograms for pathways of size L = 32. (C) The histograms for pathways of size L = 64.
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Figure 1 Overview of the proposed approach: (A) Illustration of the Homo sapiens and Mus musculus PPI networks along with HIV-1 interactions.
The dashed line that connects two nodes ui and vj indicates that the corresponding proteins are orthologous. The solid lines represent protein-
protein interactions. In the Homo sapiens network, the proteins are colored based on the HIV-1 proteins that can bind to them. Proteins with
multiple colors are susceptible to multiple HIV-1 proteins, while proteins with no color have no known interactions with HIV-1 proteins. Note
that the Mus musculus network is not colored. (B) The top-scoring alignment between two similar paths u and v. Colored nodes represent
matched proteins. (C) An example of a randomly extracted pathway in the Homo sapiens network.
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Page 3 of 10trend (results not shown). As we mentioned earlier, the
number of conserved pathways decrease as the pathway
size L gets larger. In the figure, the conserved pathways
are sorted based on their alignment scores computed by
the HMM-based local alignment method [36] (see
Methods). The alignment score reflects the degree of
conservation between the aligned pathways. We can see
that highly conserved pathways are generally more sus-
ceptible to HIV-1 interception. In fact, such pathways
typically contain more proteins that can be intercepted
by HIV-1 proteins.
Total number of human/HIV-1 protein interactions within
one pathway
To further validate our hypothesis, we checked the total
number of human/HIV-1 interactions within each path-
way. Again, we used the predicted human/HIV-1 inter-
actome in [12] to count the total number of human/
HIV-1 interactions within each pathway. Figure 4(B)
shows the p-value of the total number of HIV-1 interac-
tions within every conserved pathway (with no gaps). As
before, the baseline distribution was estimated using the
histogram of the total number of HIV-1 interactions in
randomly extracted pathways. Note that, for long con-
served pathways (L = 64), the p-values are always below
0.03. These results show that the difference in suscept-
ibility to HIV-1 interception between the conserved and
random pathways is statistically significant.
HIV-1 interaction score of conserved pathways
Finally, we evaluated the HIV-1 interaction score for
conserved pathways based on the scoring scheme in
[12]. For this evaluation, we mapped the prediction
scores of human/HIV-1 interactions onto the conserved
pathways and computed their average. In a similar way,
we computed the average HIV-1 interaction score for
each random pathway and estimated the distribution of
these average scores. Then we computed the p-values of
the average prediction scores for all the conserved path-
ways. These p-values are shown in Fig. 4(C) for the con-
served pathways with different lengths. By comparing
the results in Fig. 4(C) and those shown in Fig. 4(A,B),
we can clearly see that there exists considerable correla-
tion between these results. This is especially interesting,
if we consider the fact that our approach does not use
any extra data except for the PPI networks, while the
prediction algorithm in [12] is obtained by integrating
the information from various sources, such as gene
expression, domain and motif identification, tissue dis-
tribution, functional annotation, subcellular localization
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Figure 3 The number of proteins that interact with HIV-1 proteins in conserved pathways (with gaps) and randomly extracted pathways. (A) The
histograms for pathways of size L = 16. (B) The histograms for pathways of size L = 32. (C) The histograms for pathways of size L = 64.
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Figure 4 Statistical significance of the interactions between HIV-1 and the conserved pathways (with no gaps). (A) The p-values of the number
of human proteins that interact with HIV-1 proteins within conserved pathways with different sizes (L = 16: red, L = 32: blue, L = 64: green). (B)
The p-values of the total number of predicted human/HIV-1 interactions within conserved pathways. (C) The p-values for the average predicted
interaction scores within conserved pathways.
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Page 4 of 10and human network features, and HIV-1’s mimicry of
human protein binding partners.
GO term enrichment analysis
We also performed a Gene Ontology (GO) term enrich-
ment analysis [38] using GO::TermFinder [39]. We took
the top 20 conserved pathways of size L =6 4a n d
checked their GO terms. The complete enrichment ana-
lysis results can be found at [40]. Table 1 shows some
of the enriched GO terms, whose adjusted p-values are
smaller than 2.0e – 7. Examples of highly enriched GO
terms include: “signaling pathway”, “signal transduction”,
“cell communication”, “phosphate metabolic process”,
“response to stimulus”, “response to stress”, “protein
modification process”, “regulation of immune system
process”, which are pathways that are widely known to
be susceptible to HIV-1 interception [2,3,12,13]. There
are also more specific GO terms that are enriched, such
as “hemopoietic or lymphoid organ development” and
“lymphocyte proliferation”. Interestingly, the pathogen-
esis of HIV-associated lymphomas has been conjectured
to cause the complication of HIV infection as reported
in [41]. From all the proteins covered by the top 20 con-
served pathways, we have listed ten human proteins
with the largest number of predicted HIV-1 interactions
in Table 2. We also selected eight human proteins that
are not known to be intercepted by HIV-1, which are
shown in bold face in Table 2. We have also listed their
associated ontology keywords or GO terms based on the
UniProt database [42]. We note that many of these pro-
teins are related to the aforementioned biological pro-
cesses and they might be unidentified targets of HIV-1.
Further study on these proteins may lead to a better
understanding of the biological mechanisms of HIV-1.
Results using curated human/HIV-1 protein interactions
In order to ensure that the obtained results are biologi-
cally meaningful, we further validate our hypothesis by
testing the HIV-1 susceptibility using the curated
human/HIV-1 protein inter a c t i o nd a t ai nt h eH u m a n
Protein Interaction Database (HPID) [43]. These
human/HIV-1 interactions were reported in the litera-
ture and curated by experts and can provide another
supporting evidence that pathways which are conserved
across species have a high probability of being attacked
by HIV-1. As in our previous experiments, we counted
the number of HIV-1 interacting proteins in conserved
pathways (without allowing gaps) and compared it to
the number of HIV-1 interacting proteins in random
pathways. The resulting histograms are shown in Fig. 5.
We can see that the histograms show similar trends as
in Fig. 2, but the numbers of interacting human proteins
are relatively smaller and the separation between the
histograms of the conserved pathways and the random
pathways is less significant. This is expected since the
HPID curated interactions are sparser compared to the
predicted interactions in [12] and smaller number of
proteins in the Homo sapiens PPI network have been
mapped with the HIV-1 interactions. We have also com-
pared the total number of human/HIV-1 interactions
in conserved pathways with that in random pathways.
The resulting histograms are shown in Fig. 6. Figure 7
plots the computed p-values of both the number of the
HIV-1 interacting proteins and the total number of
Table 1 Selected GO terms enriched in the top 20
conserved pathways of size L = 64 with adjusted
p-values
Gene Ontology terms Adjusted p-values
signaling pathway 1.39e-49
signaling 4.39e-47
signal transduction 1.97e-42
regulation of cellular process 1.14e-41
signal transmission 4.46e-41
signaling process 4.94e-41
regulation of biological process 1.46e-39
biological regulation 3.09e-37
intracellular signaling pathway 7.57e-37
intracellular signal transduction 2.56e-35
cell proliferation 8.71e-34
phosphate metabolic process 2.86e-33
system development 3.63e-31
enzyme linked receptor protein signaling pathway 9.49e-31
developmental process 6.77e-30
anatomical structure development 1.73e-29
organ development 2.16e-29
cell surface receptor linked signaling pathway 1.23e-28
response to endogenous stimulus 7.55e-27
cellular response to stimulus 3.96e-26
response to stimulus 4.21e-25
protein modification process 2.11e-24
regulation of metabolic process 1.12e-23
response to hormone stimulus 1.38e-21
cell communication 6.28e-21
regulation of biosynthetic process 1.55e-15
Ras protein signal transduction 2.85e-14
response to stress 1.65e-13
RNA biosynthetic process 5.10e-13
cellular macromolecule biosynthetic process 5.49e-13
regulation of transferase activity 1.15e-12
immune system development 2.09e-12
regulation of immune system process 2.26e-12
hemopoietic or lymphoid organ development 9.12e-12
hemopoiesis 4.55e-11
neurogenesis 5.75e-08
leukocyte differentiation 6.68e-08
lymphocyte proliferation 1.43e-07
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Page 5 of 10human/HIV-1 interactions within every conserved path-
way (with no gaps). Both results show that the predicted
susceptibility of conserved pathways in the Homo
sapiens PPI network and the Mus musculus PPI network
to HIV-1 interception is statistically significant.
Conclusions
Local network alignment can effectively identify con-
served pathways that are biologically meaningful [36].
If HIV-1 is a minimalist in order to survive and there-
fore targets essential pathways [13], as other viruses do,
it is natural to expect that essential pathways that are
conserved across different species should be highly vul-
nerable to HIV-1 attacks. Our analysis based on com-
paring the Homo sapiens PPI network and the Mus
musculus PPI network indicates that our conjecture is
indeed true. This proof-of-concept study that we present
clearly shows that the comparative network analysis of
Table 2 UniProt accession numbers of selected proteins in the top 20 conserved pathways of size L = 64 with protein
names and the associated top ontology keywords and GO terms listed by the UniProt database [42]
UniProt IDs Protein names Gene Ontology terms
P04637 Cellular tumor antigen p53 apoptosis; host-virus interaction; DNA damage response; protein tetramerization
P17612 cAMP-dependent protein kinase
catalytic subunit a
hormone-mediated signaling pathway; intracellular protein kinase cascade
P28482 Mitogen-activated protein kinase 1 Ras protein signal transduction; cell cycle; transcription; interspecies interaction between
organisms; chemotaxis; synaptic transmission
P27361 Mitogen-activated protein kinase 3 Ras protein signal transduction; interspecies interaction between organisms
P05412 Transcription factor AP-1 SMAD protein signal transduction; positive regulation by host of viral transcription; transforming
growth factor (TGF) b receptor signaling pathway
P06241 Tyrosine-protein kinase Fyn T cell receptor signaling pathway; interspecies interaction between organisms
P06493 Cell division protein kinase 1 anti-apoptosis; cell division; mitosis
Q15796 Mothers against decapentaplegic
homolog 2
SMAD protein complex assembly; intracellular signaling pathway; palate development;
transcription; TGF b receptor signaling pathway
P06400 Retinoblastoma-associated protein Cell cycle; Host-virus interaction; androgen receptor signaling pathway; myoblast differentiation
P04049 RAF proto-oncogene serine/
threonine-protein kinase
Ras protein signal transduction; cell proliferation; protein amino acid phosphorylation
O14512 Suppressor of cytokine signaling 7 Ubl conjugation pathway; regulation of growth; negative regulation of signal transduction
P10721 Mast/stem cell growth factor
receptor
male gonad development; transmembrane receptor protein tyrosine; kinase signaling pathway
P15884 Transcription factor 4 cerebral cortex development; regulation of smooth muscle cell proliferation; transcription
P16410 Cytotoxic T-lymphocyte protein 4 immune response; negative regulation of regulatory T cell differentiation
P29597 Non-receptor tyrosine-protein
kinase TYK2
intracellular protein kinase cascade; peptidyl-tyrosine phosphorylation
Q13480 GRB2-associated-binding protein 1 cell proliferation; epidermal growth factor receptor signaling pathway; insulin receptor signaling
pathway
Q15503 Son of sevenless homolog 2 apoptosis; regulation of Rho protein ; signal transduction; small GTPase mediated signal
transduction
Q96TE0 Cdk inhibitor p27KIP1 cell cycle arrest
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Figure 5 The number of proteins that interact with HIV-1 proteins based on the HPID interaction data in conserved pathways (with no gaps)
and randomly extracted pathways. (A) The histograms for pathways of size L = 16. (B) The histograms for pathways of size L = 32. (C) The
histograms for pathways of size L = 64.
Qian and Yoon BMC Bioinformatics 2011, 12(Suppl 1):S19
http://www.biomedcentral.com/1471-2105/12/S1/S19
Page 6 of 10different species can provide important insights into the
mechanisms of human/HIV-1 interactions. We believe
that further studies based on aligning the networks of
various species that are susceptible to similar lenti-
viruses will lead to breakthroughs in HIV research. For
example, although chimpanzees are the human’sc l o s e s t
relative in nature, AIDS is rarely life-threatening to
them [14]. Identifying the main reasons for this differ-
ence in HIV-1 susceptibility may lead to the develop-
ment of novel therapeutics for this highly destructive
disease. Balakrishnan et al. [13] proposed a heuristic
way to search for alternative pathways that can circum-
vent HIV-intercepted pathways, whose ultimate goal is
to identify potential drug targets. In a similar way, com-
parative network analysis may also be used to identify
alternative pathways in the PPI network, by querying
known HIV-intercepted pathways in the human PPI net-
work. Although comparative network analysis is still at
an early stage and is not yet as mature as comparative
sequence analysis, it can take direct advantage of the
large-scale interaction measurements that have become
available these days and it has the potential to generate
experimentally verifiable hypotheses on the biological
mechanisms of HIV-1, which may lead to the identifica-
tion of better drug targets and innovative AIDS thera-
peutics in the future.
Methods
Protein-protein interaction (PPI) networks
We have obtained both the Homo sapiens and Mus
musculus protein-protein interaction (PPI) networks
from the open platform NATALIE [44], managed by the
Knowledge Management in Bioinformatics group of the
Humboldt-Universität Berlin. Both networks were
obtained from several open databases [45-50] as
described in [24,51]. The Homo sapiens network has
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Figure 6 The total number of human/HIV-1 protein interactions based on the HPID interaction data in conserved pathways (with no gaps) and
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histograms for pathways of size L = 64.
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Figure 7 Statistical significance of the interactions between HIV-1 and human proteins within the conserved pathways (with no gaps) according
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pathways with different sizes (L = 16: red, L = 32: blue, L = 64: green). (B) The p-values of the total number of predicted human/HIV-1
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Page 7 of 1034,979 interactions among 9,695 proteins, and the Mus
musculus network has 3,116 interactions among 3, 247
proteins. The similarity between proteins in the two net-
works were determined based on protein sequences,
protein domain information (InterProdomains) and
functional annotations (GO annotations) [51-54]. Pairs
of similar proteins in the two networks were identified
based on a minimum protein identity threshold of
a = 0.4 as in [24,51].
Human-HIV interaction data
As mentioned in [13], there are several types of interac-
tions between HIV-1 proteins and human proteins,
including direct physical interactions that are reported
in the literature, indirect interactions reported in the lit-
erature, and interactions that have been manually anno-
tated by experts [12,43]. However, many HIV-1
virologists do not agree upon the majority of these
interactions [13]. For this reason, we focus on the
human/HIV-1 interactome in [12] in our analysis, which
has been computationally predicted by integrating var-
ious types of protein features. The human/HIV-1 inter-
actome data can be obtained from the authors’ website
[55]. For further validation, we also performed similar
analysis based on the curated human/HIV-1 protein
interactions in HPID [43].
Identification of conserved pathways through local
network alignment
To align the Homo sapiens and Mus musculus PPI net-
works, we used the local network alignment algorithm
based on hidden Markov models (HMMs) [35,36]. Let
us represent the Homo sapiens and Mus musculus PPI
networks as Gh =( U,D)a n dGm =( V,E), respectively.
U ={ ui}a n dV ={ vi} represent the sets of nodes, where
each node represents a protein in a given network. D =
{dij}a n dE ={ eij} are the sets of edges, where each edge
represents the interaction between the connected pro-
teins. For the orthologous protein pairs in the Homo
sapiens and Mus musculus PPI network that have been
predicted based on the method in [51], we define the
node similarity score s(u, v) between a pair of proteins
u Î U and v Î V as follows:
suv
uv
(,)
,
,
=
⎧
⎨
⎩
1
0
if   and   are orthologous
otherwise.
(1)
The interaction reliability scores between two nodes
are binary for both PPI networks. For example, the
interaction score wh(ui,uj)b e t w e e nu i and uj in the
Homo sapiens network is defined as:
wuu
uu
hi j
ij (,)
,
,
=
−∞
0 if intersection between   and   exists;
oth herwise.
⎧
⎨
⎩
(2)
The interaction reliability score wm(vi,v j) between vi
and vj in the Mus musculus network is defined in a
similar way.
In order to find the pathways that are conserved in
both PPI networks, we first search for the best matching
pair of paths u = u1u2 … uL, (ui Î U) and v = v1v2 … vL,
(vi Î V) in the respective networks (Fig. 1) that maxi-
mizes a predefined pathway alignment score S(u,v). The
pathway alignment score S(u,v)i n t e g r a t e st h esimilarity
score s(ui,v i) between the aligned nodes ui and vi (1 ≤ i ≤
L), the interaction reliability score wh(ui,ui+1)b e t w e e nui
and ui+1 (1 ≤ i ≤ L – 1), the interaction reliability score
wm(vj,vj+1)b e t w e e nvj and vj+1 (1 ≤ j ≤ L – 1), and the
penalty for potential gaps in the alignment. We denote
the number of nodes in a pathway as L. In this paper, we
search for conserved pathways of size L=16, 32, 64.
Based on the HMM framework [35,36], we transform the
problem of “finding the best matching pair of paths” to a
problem of “finding the optimal pair of state sequences
in the two HMMs” that jointly maximize the observation
probability of a virtual path (see Fig. 1). We use two dif-
ferent types of settings for finding conserved pathways,
where we do not allow gaps in the pathway alignment in
one setting while we allow gaps in the other setting. In
general, the two setting will yield different predictions.
We can find the best matching pair of paths in the given
networks using dynamic programming. For this purpose,
we first define the score for the most probable pair of a
subsequence paths of length t (≤ L) as follows:
yt jl yt ik w u u w v v su v
ik
hi j mkl jl (,,) m a x ( ,, ) ( , ) ( , ) ( , )
,
=− + + + ⎡ ⎣ ⎤ ⎦ 1. . (3)
Next, we find the optimal pair of paths (u*, v*)
SSL j l
jl
(* ) m a x ( ) m a x ( , , ) ,
,
u*, v u, v
u,v
= [] =  (4)
by computing the score (3) iteratively. As discussed in
[35,36], we can add auxiliary states to the HMMs that
represent the PPI networks to find gapped path align-
ments. Instead of finding only the best matching pair of
paths, we can also search for the top k path pairs by
replacing the max operator in (4) and (3) by an operator
that finds the k largest scores. The computational com-
plexity of the described dynamic programming algo-
rithm is only O(kLM1M2)f o rf i n d i n gt h et o pk pairs of
matching paths, where M1 is the number of edges (i.e.,
interactions) in Gh,a n dM2 is the number of edges in
Gm. Note that the computational complexity is linear
with respect to each parameter k, L, M1,a n dM2.T o
avoid multiple occurrences of the same protein in the
conserved pathways that are predicted by the algorithm,
we incorporate a “look-back” step into each iteration of
the dynamic programming algorithm [36].
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Page 8 of 10Extraction of random pathways
In order to extract random pathways from the Homo
sapiens PPI network, we performed random walks on
the network starting from a randomly selected node in
network Gh.W er a n d o m l yw a l ko nt h en e t w o r kt o
choose a random pathway, until the size of the pathway
reaches a pre-specified size L. During this random walk,
we avoid visiting a node that has been previously visited,
so that the extracted random pathway contains only
distinct nodes.
Comparison between conserved pathways and random
pathways
To compare the HIV-1 susceptibility of conserved path-
ways with that of random pathways, we computed the
following values: (1) The number of proteins within
these pathways that have been predicted to be inter-
cepted by at least one of the HIV-1 proteins according
to the human/HIV-1 interactome in [12]. (2) The total
number of predicted human/HIV-1 protein interactions
within these pathways; (3) The average HIV interaction
scores within pathways. We also computed the p-values
of the estimated results for conserved pathways, accord-
ing to the process described in the next subsection.
Finally, for GO term enrichment analysis, we used an
open source software called the GO::TermFinder [39].
Computing p-values
In order to evaluate the statistical significance of the
estimated results in conserved pathways, we first
extract a large number of random pathways (3, 000)
from the Homo sapiens PPI network, based on random
walk. For each random pathway, we also estimate the
indices of HIV-1 susceptibility (i.e., the number of
human proteins intercepted by HIV-1; the total num-
ber of human/HIV-1 interactions, the average interac-
tion scores among the proteins in each pathway).
Baseline distributions of different indices are estimated
from these results. We can either model the baseline
distributions using Gumbel distributions [56] or simply
use histograms. The latter approach was adopted in
this paper. Once we have estimated the baseline distri-
butions, we can compute the p-values of the estimated
results in conserved pathways according to the esti-
mated distributions.
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